Press Releases

August 25, 2020

AI-based OCT analysis of AREDS2 10-Y follow-on study demonstrates superior performance over retina specialists

July 28, 2020

ForeseeHome AMD home monitoring real-world data analysis compares favorably to HOME study

June 17, 2020

Home OCT longitudinal home-based study with patient self-operated device has begun

February 25, 2020

AI-based Notal OCT Analyzer successfully tracks exudative AMD disease activity across longitudinal data sets from home OCT and in-office OCT devices

February 11, 2020

AI-based retinal fluid analytics of serial Notal Vision home OCT images offers insights into retinal disease dynamics

SCANLY Home OCT FDA Intended Use

SCANLY Home OCT has not been approved by FDA for use other than described in the following Intend Use: The Notal Vision Home Optical Coherence Tomography (OCT) System is an Artificial Intelligence (AI)-based Home Use device indicated for visualization of intraretinal and subretinal hypo-reflective spaces in a 10 by 10-degrees area centered on the point of fixation of eyes diagnosed with neovascular age-related macular degeneration (NV-AMD). In addition, it provides segmentation and an estimation of the volume of hypo-reflective spaces. The Notal Home OCT device is intended for imaging at home between regularly scheduled clinic assessments and not intended to be used to make treatment decisions or replace standard-of care regularly scheduled examinations and clinical testing as needed, including in-office imaging and assessments for changes in vision, by an ophthalmologist.

See also Warnings and Precautions.

ForeseeHome FDA Intended Use

ForeseeHome has not been approved by FDA for use other than described in the following Indication for Use: The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration as an aid in monitoring progression of disease factors causing metamorphopsia including, but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.

Media enquiries? Reach out to our Media Contact